Skip to main content

ProShare Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in ALNY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$38,686,569
-$18,889,112 QoQ
Shares Held
128,514
-26.1% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#96
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. ALNY ranks #3 (11.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page
128,514 $38,686,569

All Filings in ALNY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,686,569 128,514
2026-03-31 $57,575,681 174,013
2025-12-31 $83,934,769 211,077
2025-09-30 $2,111,736 4,631
2025-06-30 $1,382,947 4,241
2025-03-31 $1,576,916 5,840
2024-12-31 $1,437,744 6,110
2024-09-30 $2,086,377 7,586
2024-06-30 $1,897,587 7,809
2024-03-31 $1,319,195 8,827
2023-12-31 $1,534,725 8,018
2023-09-30 $1,447,261 8,172
2023-06-30 $1,530,346 8,057
2023-03-31 $1,765,620 8,814
2022-12-31 $2,861,543 12,041
2022-09-30 $2,403,521 12,008
2022-06-30 $1,661,085 11,389
2022-03-31 $2,480,375 15,190
2021-12-31 $3,365,484 19,846
2021-09-30 $5,325,763 28,207
2021-06-30 $4,300,552 25,369
2021-03-31 $2,595,919 18,386
2020-12-31 $2,601,609 20,017
2020-09-30 $3,013,046 20,694
2020-06-30 $2,987,674 20,172
2020-03-31 $1,892,792 17,389